Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21908490 | 0.95 | HRH3 (0.33) | — | |
| SCHEMBL21102928 | 0.87 | ALDH1A1 (0.34) | GAAKDM4EALDH1A1 | |
| SCHEMBL21102929 | 0.84 | ALDH1A1 (0.32) | GAAKDM4EALDH1A1 | |
| SCHEMBL11526738 | 0.76 | KDM4E (0.34) | KDM4EMEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL11528763 | 0.72 | CARM1 (0.34) | KDM4EMEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL15003162 | 0.71 | — | — | |
| SCHEMBL9358391 | 0.71 | TRPA1 (0.40) | GAA | |
| SCHEMBL19764500 | 0.69 | KDM4E (0.31) | KDM4EMEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL17541209 | 0.69 | DHFR (0.36) | — | |
| SCHEMBL9358209 | 0.68 | LMNA (0.38) | KDM4EMEN1ALDH1A1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10633590-B2 | Liquid crystal composition and liquid crystal display device including the same | DIC CORPORATION (JP) | 2020-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10633590-B2 | Liquid crystal composition and liquid crystal display device including the same | LASP1, UACA, CCDC22 | GAA 4678/4885KDM4E 4273/4885MEN1 3452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.